Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionUDP-xylosyltransferase activity

GXYLT2 POGLUT3

5.63e-0411652GO:0035252
GeneOntologyMolecularFunctionxylosyltransferase activity

GXYLT2 POGLUT3

5.63e-0411652GO:0042285
GeneOntologyMolecularFunctionvoltage-gated chloride channel activity

CLCN1 CLCN4

5.63e-0411652GO:0005247
GeneOntologyMolecularFunctiondynein light chain binding

DYNC1I1 DYNC1I2

6.74e-0412652GO:0045503
GeneOntologyMolecularFunctionneuropeptide receptor activity

PRLHR TACR3 NMBR

6.87e-0453653GO:0008188
GeneOntologyMolecularFunctionpentosyltransferase activity

GXYLT2 POGLUT3 TIPARP

8.07e-0456653GO:0016763
GeneOntologyMolecularFunctionpeptidase activity

BMP1 MALT1 TMPRSS15 ADAMTS16 RHBDL1 OTUD4 CPZ MMP26

1.24e-03654658GO:0008233
GeneOntologyMolecularFunctiondynein heavy chain binding

DYNC1I1 DYNC1I2

1.37e-0317652GO:0045504
GeneOntologyMolecularFunctionvoltage-gated monoatomic anion channel activity

CLCN1 CLCN4

1.37e-0317652GO:0008308
GeneOntologyMolecularFunctionUDP-glycosyltransferase activity

B3GALT2 GXYLT2 POGLUT3 GALNT4

1.56e-03153654GO:0008194
DomainDYNC1I1/DYNC1I2

DYNC1I1 DYNC1I2

1.31e-052682IPR025956
DomainDynein_IC2

DYNC1I1 DYNC1I2

1.31e-052682PF11540
DomainCUB

BMP1 TMPRSS15 KREMEN2 CDCP2

3.01e-0549684PF00431
DomainCUB

BMP1 TMPRSS15 KREMEN2 CDCP2

3.26e-0550684SM00042
Domain-

BMP1 TMPRSS15 KREMEN2 CDCP2

3.81e-05526842.60.120.290
DomainCUB

BMP1 TMPRSS15 KREMEN2 CDCP2

4.11e-0553684PS01180
DomainCUB_dom

BMP1 TMPRSS15 KREMEN2 CDCP2

5.49e-0557684IPR000859
DomainWD40

DCAF12L1 MIOS WDFY4 DENND3 DYNC1I1 DYNC1I2

4.29e-04268686SM00320
DomainCl-channel_core

CLCN1 CLCN4

4.63e-049682IPR014743
Domain-

CLCN1 CLCN4

4.63e-0496821.10.3080.10
DomainVoltage_CLC

CLCN1 CLCN4

4.63e-049682PF00654
DomainCl-channel_volt-gated

CLCN1 CLCN4

4.63e-049682IPR001807
DomainWD40_repeat

DCAF12L1 MIOS WDFY4 DENND3 DYNC1I1 DYNC1I2

4.64e-04272686IPR001680
DomainWD_REPEATS_1

DCAF12L1 MIOS WDFY4 DENND3 DYNC1I1 DYNC1I2

5.21e-04278686PS00678
DomainWD_REPEATS_2

DCAF12L1 MIOS WDFY4 DENND3 DYNC1I1 DYNC1I2

5.30e-04279686PS50082
DomainWD_REPEATS_REGION

DCAF12L1 MIOS WDFY4 DENND3 DYNC1I1 DYNC1I2

5.30e-04279686PS50294
DomainWD40_repeat_dom

DCAF12L1 MIOS WDFY4 DENND3 DYNC1I1 DYNC1I2

7.36e-04297686IPR017986
Domain-

DCAF12L1 MIOS WDFY4 DENND3 DYNC1I1 DYNC1I2

1.33e-033336862.130.10.10
DomainWD40/YVTN_repeat-like_dom

DCAF12L1 MIOS WDFY4 DENND3 DYNC1I1 DYNC1I2

1.37e-03335686IPR015943
DomainCBS_dom

CLCN1 CLCN4

2.38e-0320682IPR000644
DomainCBS

CLCN1 CLCN4

2.38e-0320682PF00571
DomainCBS

CLCN1 CLCN4

2.38e-0320682PS51371
DomainIg_2

MALT1 TARM1 FCRL5

2.39e-0373683PF13895
DomainWD40

DCAF12L1 WDFY4 DENND3 DYNC1I1 DYNC1I2

2.53e-03259685PF00400
DomainMetalloPept_cat_dom

BMP1 ADAMTS16 MMP26

3.22e-0381683IPR024079
Domain-

BMP1 ADAMTS16 MMP26

3.22e-03816833.40.390.10
DomainZnMc

BMP1 MMP26

4.98e-0329682SM00235
DomainPeptidase_Metallo

BMP1 MMP26

4.98e-0329682IPR006026
Domainig

MALT1 NPTN FCRL5 FCMR

5.09e-03190684PF00047
DomainImmunoglobulin

MALT1 NPTN FCRL5 FCMR

5.09e-03190684IPR013151
DomainZINC_PROTEASE

BMP1 ADAMTS16 MMP26

5.49e-0398683PS00142
DomainProt-tyrosine_phosphatase-like

GAK PTPRG MTMR8

5.64e-0399683IPR029021
DomainGal_Oxidase_b-propeller

KLHL24 KLHL14

6.80e-0334682IPR015916
Domain7TM_GPCR_Srsx

PRLHR OR51I1 NMBR

7.93e-03112683SM01381
DomainDeath_domain

MALT1 IRAK1

8.44e-0338682IPR000488
DomainCYSTEINE_SWITCH

ADAMTS16 MMP26

9.77e-0341682PS00546
Domain-

MALT1 NPTN TARM1 POGLUT3 PTPRG FCRL5 FCMR

1.02e-026636872.60.40.10
DomainBTB-kelch_protein

KLHL24 KLHL14

1.07e-0243682IPR017096
DomainPept_M10_metallopeptidase

ADAMTS16 MMP26

1.07e-0243682IPR001818
Pubmed

The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4.

MALT1 IRAK1 MAP3K7

6.50e-07970316831874
Pubmed

Cloning and characterization of two cytoplasmic dynein intermediate chain genes in mouse and human.

DYNC1I1 DYNC1I2

3.99e-06270210049579
Pubmed

TAK1 lessens the activity of the paracaspase MALT1 during T cell receptor signaling.

MALT1 MAP3K7

3.99e-06270232388054
Pubmed

Mouse cytoplasmic dynein intermediate chains: identification of new isoforms, alternative splicing and tissue distribution of transcripts.

DYNC1I1 DYNC1I2

3.99e-06270220657784
Pubmed

Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.

CMKLR2 CLCN4 SETD6 VPS35L TATDN2 PAQR6 CHST7 LRRC8D DYNC1I1 KMO DYNC1I2 FCMR

9.60e-061293701215342556
Pubmed

Pellino 3b negatively regulates interleukin-1-induced TAK1-dependent NF kappaB activation.

IRAK1 MAP3K7

2.39e-05470218326498
Pubmed

Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway.

IRAK1 MAP3K7

2.39e-05470211259596
Pubmed

Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.

MALT1 IRAK1

2.39e-05470224491438
Pubmed

Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA.

IRAK1 MAP3K7

2.39e-05470235785771
Pubmed

Interaction of SQSTM1 with the motor protein dynein--SQSTM1 is required for normal dynein function and trafficking.

DYNC1I1 DYNC1I2

3.98e-05570225015291
Pubmed

PINK1 positively regulates IL-1β-mediated signaling through Tollip and IRAK1 modulation.

IRAK1 MAP3K7

3.98e-05570223244239
Pubmed

Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma.

DYNC1I1 DYNC1I2

3.98e-05570230250299
Pubmed

Animal models of lysosomal disease: an overview.

DYNC1I1 DYNC1I2

5.96e-0567029728334
Pubmed

HSP90 is required for TAK1 stability but not for its activation in the pro-inflammatory signaling pathway.

IRAK1 MAP3K7

5.96e-05670219026643
Pubmed

Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFkappaB activation pathways bifurcate at IL-1 receptor-associated kinase modification.

IRAK1 MAP3K7

5.96e-05670217197697
Pubmed

USP2a positively regulates TCR-induced NF-κB activation by bridging MALT1-TRAF6.

MALT1 MAP3K7

5.96e-05670223264041
Pubmed

Expression of CLCN voltage-gated chloride channel genes in human blood vessels.

CLCN1 CLCN4

5.96e-05670210198195
Pubmed

Herpesvirus tegument protein activates NF-kappaB signaling through the TRAF6 adaptor protein.

IRAK1 MAP3K7

5.96e-05670218682563
Pubmed

Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein.

IRAK1 MAP3K7

8.33e-05770212874243
Pubmed

Temporal profiles of the subcellular localization of Bim, a BH3-only protein, during middle cerebral artery occlusion in mice.

DYNC1I1 DYNC1I2

8.33e-05770212142566
Pubmed

FAM177A1 Inhibits IL-1β-Induced Signaling by Impairing TRAF6-Ubc13 Association.

IRAK1 MAP3K7

8.33e-05770234799425
Pubmed

The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.

MALT1 MAP3K7

8.33e-05770221896478
Pubmed

Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex.

IRAK1 MAP3K7

8.33e-05770212496252
Pubmed

STUB1 is essential for T-cell activation by ubiquitinating CARMA1.

MALT1 MAP3K7

8.33e-05770223322406
Pubmed

A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins.

DYNC1I1 DYNC1I2

8.33e-05770211751894
Pubmed

A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system.

DYNC1I1 DYNC1I2

8.33e-05770211163259
Pubmed

Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.

IRAK1 MAP3K7

1.11e-04870211544529
Pubmed

Pellino3 is a novel upstream regulator of p38 MAPK and activates CREB in a p38-dependent manner.

IRAK1 MAP3K7

1.11e-04870215917247
Pubmed

Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.

MALT1 MAP3K7

1.11e-04870217948050
Pubmed

The CARMA1-Bcl10 signaling complex selectively regulates JNK2 kinase in the T cell receptor-signaling pathway.

MALT1 MAP3K7

1.11e-04870217189706
Pubmed

HIV-1 uncoating is facilitated by dynein and kinesin 1.

DYNC1I1 DYNC1I2

1.11e-04870225231297
Pubmed

HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus.

DYNC1I1 DYNC1I2

1.11e-04870225818806
Pubmed

Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol.

IRAK1 MAP3K7

1.11e-04870212242293
Pubmed

Changing expression of chloride channels during preimplantation mouse development.

CLCN1 CLCN4

1.42e-04970223115349
Pubmed

Senescence-associated genes in normal human oral keratinocytes.

CMKLR2 CYP4B1

1.42e-04970212837283
Pubmed

Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression.

IRAK1 MAP3K7

1.42e-04970221220427
Pubmed

Transport of the outer dynein arm complex to cilia requires a cytoplasmic protein Lrrc6.

DYNC1I1 DYNC1I2

1.42e-04970227353389
Pubmed

The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.

MALT1 MAP3K7

1.42e-04970218625728
Pubmed

β-TrCP-mediated IRAK1 degradation releases TAK1-TRAF6 from the membrane to the cytosol for TAK1-dependent NF-κB activation.

IRAK1 MAP3K7

1.78e-041070222851693
Pubmed

The TNF family member 4-1BBL sustains inflammation by interacting with TLR signaling components during late-phase activation.

IRAK1 MAP3K7

1.78e-041070224084649
Pubmed

Regulation and function of IKK and IKK-related kinases.

MALT1 MAP3K7

2.17e-041170217047224
Pubmed

TRIM38 inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3.

IRAK1 MAP3K7

2.17e-041170224434549
Pubmed

MALT1-ubiquitination triggers non-genomic NF-κB/IKK signaling upon platelet activation.

MALT1 MAP3K7

2.17e-041170225748427
Pubmed

Transfer of cGAMP into Bystander Cells via LRRC8 Volume-Regulated Anion Channels Augments STING-Mediated Interferon Responses and Anti-viral Immunity.

LRRC8D CYFIP2

2.60e-041270232277911
Pubmed

Phosphorylation and ubiquitination of the IkappaB kinase complex by two distinct signaling pathways.

MALT1 MAP3K7

2.60e-041270217363905
Pubmed

Direct activation of protein kinases by unanchored polyubiquitin chains.

IRAK1 MAP3K7

3.07e-041370219675569
Pubmed

Cytoplasmic dynein nomenclature.

DYNC1I1 DYNC1I2

3.07e-041370216260502
Pubmed

A Pellino-2 variant is associated with constitutive NLRP3 inflammasome activation in a family with ocular pterygium-digital keloid dysplasia.

IRAK1 MAP3K7

3.58e-041470236776133
Pubmed

Activation of IkappaB kinase beta by protein kinase C isoforms.

IRAK1 MAP3K7

3.58e-041470210022904
Pubmed

BICD2, dynactin, and LIS1 cooperate in regulating dynein recruitment to cellular structures.

DYNC1I1 DYNC1I2

3.58e-041470222956769
Pubmed

Behavioral and other phenotypes in a cytoplasmic Dynein light intermediate chain 1 mutant mouse.

DYNC1I1 DYNC1I2

3.58e-041470221471385
Pubmed

Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains.

IRAK1 MAP3K7

4.12e-041570223986494
Pubmed

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

MALT1 MAP3K7

4.12e-041570215125833
Pubmed

Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR .

IRAK1 MAP3K7

5.33e-041770212609980
Pubmed

SASH1 is a scaffold molecule in endothelial TLR4 signaling.

IRAK1 MAP3K7

6.68e-041970223776175
Pubmed

Purification and Transcriptomic Analysis of Mouse Fetal Leydig Cells Reveals Candidate Genes for Specification of Gonadal Steroidogenic Cells.

ADAMTS16 TACR3

6.68e-041970225855264
Pubmed

Promyelocytic leukemia protein interacts with the apoptosis-associated speck-like protein to limit inflammasome activation.

DRC7 TMPRSS15

8.18e-042170224407287
Pubmed

Neuronal-Specific TUBB3 Is Not Required for Normal Neuronal Function but Is Essential for Timely Axon Regeneration.

DYNC1I1 DYNC1I2

8.18e-042170230110642
Pubmed

Distinct dynein complexes defined by DYNLRB1 and DYNLRB2 regulate mitotic and male meiotic spindle bipolarity.

DYNC1I1 DYNC1I2

9.83e-042370236973253
Pubmed

mTOR Inhibition via Rapamycin Treatment Partially Reverts the Deficit in Energy Metabolism Caused by FH Loss in RPE Cells.

BMP1 PTPRG DYNC1I2

1.04e-039870334943047
Pubmed

Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.

IRAK1 MAP3K7

1.07e-032470220448286
Pubmed

Placentation defects are highly prevalent in embryonic lethal mouse mutants.

RUNDC1 NDUFB8 CYFIP2

1.20e-0310370329539633
Pubmed

Recapitulating early development of mouse musculoskeletal precursors of the paraxial mesoderm in vitro.

GREB1 CHST7

1.67e-033070229555813
GeneFamilyImmunoglobulin like domain containing

MALT1 NPTN TARM1 FCRL5 FCMR

2.08e-04193515594
GeneFamilyChloride voltage-gated channels

CLCN1 CLCN4

3.46e-0410512302
GeneFamilyBone morphogenetic proteins|Astacins

BMP1 BMP15

4.22e-0411512455
GeneFamilyDyneins, cytoplasmic

DYNC1I1 DYNC1I2

5.97e-0413512538
GeneFamilyWD repeat domain containing

DCAF12L1 WDFY4 DENND3 DYNC1I1 DYNC1I2

8.39e-04262515362
GeneFamilyKelch like|BTB domain containing

KLHL24 KLHL14

6.25e-0342512617
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500

DCAF12L1 ADAMTS16 RBM46 GREB1 DYNC1I1 TIPARP

3.43e-06134656gudmap_developingGonad_e18.5_ovary_500_k1
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_1000

GXYLT2 DCAF12L1 ADAMTS16 RBM46 GREB1 DYNC1I1 TIPARP

4.73e-06219657gudmap_developingGonad_e16.5_ovary_1000_k5
CoexpressionAtlasB cells, B.MZ.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21.35+, Spleen, avg-1

MALT1 MFHAS1 KLHL14 WDFY4 DENND3 KMO FCMR

6.12e-05326657GSM538210_500
CoexpressionAtlasDevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000

DCAF12L1 ADAMTS16 RBM46 GREB1 DYNC1I1 TIPARP

7.33e-05230656gudmap_developingGonad_e18.5_ovary_1000_k5
CoexpressionAtlasCD positive, CD19 Control, 19+ 4- 8-, Spleen, avg-6

MALT1 KLHL24 KLHL14 WDFY4 DENND3 KMO FCMR

7.82e-05339657GSM403988_500
CoexpressionAtlasB cells, B.MZ.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23- CD21/35+, Spleen, avg-2

MALT1 MFHAS1 KLHL14 WDFY4 DENND3 KMO FCMR

8.11e-05341657GSM538211_500
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_200

DCAF12L1 RBM46 TIPARP

8.49e-0528653gudmap_developingGonad_e12.5_ovary_k3_200
CoexpressionAtlasB cells, B.Fo.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23+, Spleen, avg-3

MALT1 KLHL24 KLHL14 WDFY4 DENND3 KMO FCMR

8.72e-05345657GSM538201_500
CoexpressionAtlasB cells, B.T2.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3

MALT1 KLHL24 KLHL14 WDFY4 DENND3 KMO FCMR

9.21e-05348657GSM538216_500
CoexpressionAtlasB cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3

MALT1 KLHL24 KLHL14 WDFY4 DENND3 KMO FCMR

9.88e-05352657GSM538198_500
CoexpressionAtlasB cells, B.T1.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23-, Spleen, avg-3

MALT1 KLHL24 KLHL14 WDFY4 DENND3 KMO FCMR

1.01e-04353657GSM538213_500
CoexpressionAtlasB cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3

MALT1 KLHL24 KLHL14 WDFY4 DENND3 KMO FCMR

1.16e-04361657GSM538219_500
CoexpressionAtlasB cells, B.FrF.BM, CD19+ IgM+ AA4.1- HSA+, Bone marrow, avg-3

MALT1 KLHL24 KLHL14 WDFY4 DENND3 KMO FCMR

1.28e-04367657GSM399440_500
CoexpressionAtlasB cells, B.FrE.BM, CD19+ IgM+ AA4.1+ HSA+, Bone marrow, avg-3

MALT1 KLHL24 KLHL14 WDFY4 DENND3 KMO FCMR

1.49e-04376657GSM399438_500
CoexpressionAtlasDevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000

DCAF12L1 ADAMTS16 RBM46 GREB1 TIPARP

1.64e-04168655gudmap_developingGonad_P2_ovary_1000_k4
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000

DCAF12L1 ADAMTS16 RBM46 GREB1 DYNC1I1

2.21e-04179655gudmap_developingGonad_e14.5_ ovary_1000_k5
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_500

ADAMTS16 RBM46 TIPARP

3.54e-0445653gudmap_developingGonad_e16.5_epididymis_500_k3
CoexpressionAtlasDevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#3_top-relative-expression-ranked_500

DCAF12L1 ADAMTS16 RBM46 TIPARP

4.01e-04113654gudmap_developingGonad_e16.5_ovary_500_k3
ToppCellFetal_29-31_weeks-Immune-B_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

TMPRSS15 KREMEN2 FCRL5 KLHL14 WDFY4 KMO FCMR

1.47e-0818170757f20341c3e9f9f6ed5b6c181605ad35bae91414
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KREMEN2 FCRL5 KLHL14 WDFY4 KMO CYFIP2 FCMR

2.05e-08190707e1af324b4522045875fb64766cf118cd7b41704a
ToppCellFetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

KREMEN2 FCRL5 KLHL14 WDFY4 KMO CYFIP2 FCMR

2.13e-0819170784452125d1b5b76974e3f9126f611eff16d45c25
ToppCellB_cells-Naive_B_cells_|World / Immune cells in Kidney/Urine in Lupus Nephritis

CLCN4 FCRL5 KLHL14 WDFY4 KMO FCMR

4.27e-0718270663c3b63315276b66667d49fab09661ac320e7a36
ToppCellFetal_29-31_weeks-Immune-B_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FCRL5 KLHL14 WDFY4 KMO CYFIP2 FCMR

4.55e-07184706f4c9272d5cc4a70df051413b5c60ca6d1d80eb84
ToppCellImmune-B_cell|World / Lineage, Cell type, age group and donor

KREMEN2 FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

5.00e-07187706795690c6306c366e733279491138d0cd9b469b21
ToppCellwk_15-18-Hematologic_Lymphocytic-B-Late_pre-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

KREMEN2 FCRL5 KLHL14 KMO CYFIP2 FCMR

5.32e-071897063012e67093ca7c281ee8f1b68064646961f250f9
ToppCellFetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

KREMEN2 FCRL5 KLHL14 WDFY4 KMO CYFIP2

5.49e-07190706424550418c1bd4eb070cf3c41cf09fa9d89aef37
ToppCellwk_20-22-Hematologic_Lymphocytic-B-Late_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

KREMEN2 FCRL5 KLHL14 KMO CYFIP2 FCMR

5.66e-071917062b05be1888cccd03a32341bcb1de4a899d4179fd
ToppCellwk_20-22-Hematologic_Lymphocytic-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

KREMEN2 FCRL5 KLHL14 KMO CYFIP2 FCMR

6.20e-07194706aca97fbf1a932df457a82709c2a2dc9081e018df
ToppCellsevere-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CLCN4 FCRL5 KLHL14 WDFY4 KMO FCMR

6.39e-0719570673e39005a597e13aea571ae6ae5824d1c7448b71
ToppCell10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KREMEN2 FCRL5 KLHL14 KMO CYFIP2 FCMR

6.39e-07195706ecaaa3d071e763c40d05d088fbf9e8ca06f78f47
ToppCellmild-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CLCN4 FCRL5 KLHL14 WDFY4 KMO FCMR

6.58e-071967061988088dd7e1ba947339fd1331beed482955e607
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FCRL5 KLHL14 WDFY4 KMO CYFIP2 FCMR

6.98e-07198706863765ccc0205dc28864dae85af339c283194c96
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CLCN4 FCRL5 KLHL14 WDFY4 FCMR

2.02e-06131705a3a086ce6e69707ca6a042f3b15c130f81909acb
ToppCellPND07-28-samps-Lymphocyte-B_cell-B_cell_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass

FCRL5 KLHL14 KMO CYFIP2 FCMR

2.51e-061377052544d1256f11da6e3bad24a871b2253e0ab20d01
ToppCellPND07-28-samps-Lymphocyte-B_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass

FCRL5 KLHL14 KMO CYFIP2 FCMR

2.51e-06137705874e2eaa7846a2832f46b77c726d79f220a4a1cd
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CLCN4 FCRL5 WDFY4 KMO FCMR

5.36e-061607058396afbc7d919ba190863d50aa0ef8b9942a9866
ToppCell10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KREMEN2 FCRL5 KLHL14 KMO FCMR

6.05e-0616470569b6566fb88c7449b7ab9056b57508cb6a1aa2af
ToppCellB_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

CLCN1 FCRL5 WDFY4 KMO FCMR

6.05e-06164705f45013706a917f0f0d69c23f288128f252cd60c7
ToppCellfacs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

6.23e-0616570536415924d05373e9dd3665be599f4f3f40bf0497
ToppCellfacs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

6.23e-0616570556310fddd3d8e4afdfde066d26cee9747e5b8c6a
ToppCelldroplet-Thymus-nan-3m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MALT1 FCRL5 CHST7 DENND3 FCMR

6.42e-06166705c0af93db981dfd448abc7efcd257f3e5ff066aae
ToppCellControl-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations)

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

6.80e-06168705a7159a35fe37f8c241cf8d391debe271e0698105
ToppCell10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive|lymph-node_spleen / Manually curated celltypes from each tissue

KREMEN2 FCRL5 WDFY4 KMO FCMR

6.80e-06168705494d5a11154ff22fedb25f4036d730cef376da60
ToppCellLPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

7.20e-0617070592e0873f618b2fa60c4d555b10f234d5cbcf3325
ToppCellLPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

7.20e-06170705c181991f933b779f99afc3782f292306f209e2ac
ToppCellLPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

7.20e-0617070556284fbfd1e53f67c8c0b7fba64505a4002adba2
ToppCellfacs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MALT1 KLHL14 WDFY4 KMO FCMR

7.84e-0617370549030c2dd04b592655df1a667e2f90efb499e0a5
ToppCellfacs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MALT1 KLHL14 WDFY4 KMO FCMR

7.84e-061737051cfbab6603f8baf8e238837bb72740c43a7dc0ec
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CLCN4 FCRL5 KLHL14 WDFY4 FCMR

8.52e-06176705ad05dd934f4ac2e656b3455de091f4c8772de6c8
ToppCellControl-B_cells-B_cells|Control / group, cell type (main and fine annotations)

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

8.52e-06176705d2c353783bd78dc24f28e00d917b88d8294fb5df
ToppCellCOVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

8.76e-06177705f54691e5558091c1734ab15153a10bff15ed171e
ToppCellCOVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations)

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

8.76e-06177705653bb62a3744d4024ab3186ee01d410ed62832a6
ToppCell10x5'v1-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

FCRL5 KLHL14 WDFY4 KMO FCMR

8.76e-06177705325c10674b18727ddd50bf088a9c6f4ef29aa809
ToppCellNS-moderate-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FCRL5 KLHL14 WDFY4 KMO FCMR

8.76e-06177705320fd77c7c98e9305dcc34a168ec9d674539ed65
ToppCellChildren_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

9.51e-0618070540a12eb852373ae3d7c8d9bca376b0ae99f724b3
ToppCellIPF-Lymphoid-B|World / Disease state, Lineage and Cell class

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

9.51e-0618070530f9398c9b784f49470847a025bac90687e997a1
ToppCelldroplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GVINP1 FCRL5 DENND3 DYNC1I1 DYNC1I2

9.51e-06180705dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCelldroplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GVINP1 FCRL5 DENND3 DYNC1I1 DYNC1I2

9.51e-06180705423454e3390080ae03bb3cbb267255ebfe4df080
ToppCellnucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

9.76e-061817058d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86
ToppCell10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

CMKLR2 BMP1 GXYLT2 RBM46 CPZ

1.00e-05182705ba066ff9029cc052b76e2330ec168cb2e9b7e498
ToppCellIPF-Lymphoid-B|IPF / Disease state, Lineage and Cell class

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

1.03e-05183705e37d2c015c34471a8a54a0299e94b0371e1ada5a
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MALT1 FCRL5 WDFY4 CYFIP2 FCMR

1.03e-05183705544939a0bfef082d361d88ef70d6f0923b8d9af9
ToppCell10x5'-GI_small-bowel-Lymphocytic_B-Naive_B_cells|GI_small-bowel / Manually curated celltypes from each tissue

FCRL5 KLHL14 WDFY4 KMO FCMR

1.03e-05183705be294d22b91dbcf1e8d22e6a31c39b5caaad4751
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KREMEN2 KLHL14 WDFY4 KMO CYFIP2

1.09e-051857050fa7970709dc957dea95fabbd83263a0335babd5
ToppCellCOPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class

KLHL24 FCRL5 KLHL14 WDFY4 FCMR

1.09e-05185705925e79c35c381dd44ec5fb921dca09ce43140135
ToppCellCOVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

1.09e-05185705e8f1ad580f19705b5ca1d7d8867b2125f4891684
ToppCelldroplet-Liver-Npc-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GVINP1 MFHAS1 CYP4B1 CHST7 DENND3

1.11e-0518670575258d88e23112fd1f0f7c71ef0366abb400d33e
ToppCellChildren_(3_yrs)-Immune-B_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

1.11e-05186705aa576748921a318798b911a611f05319b95e8d5e
ToppCell10x5'-Liver-Lymphocytic_B-Naive_B_cells|Liver / Manually curated celltypes from each tissue

FCRL5 KLHL14 WDFY4 KMO FCMR

1.11e-0518670523efdcedbe67f5e6c59106e052f570cd0338f1c1
ToppCellBLOOD--(2)_Naive_B_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

CLCN4 FCRL5 KLHL14 KMO FCMR

1.11e-051867052e55a3892459152fc4a3a7834ccbf5d71b65d29a
ToppCellBL-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FCRL5 KLHL14 WDFY4 KMO FCMR

1.11e-0518670527d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FCRL5 KLHL14 WDFY4 KMO FCMR

1.11e-05186705459a7e97bbac2b2cd253aa4ab38d0e4ae6191e8b
ToppCellfacs-MAT-Fat-3m-Lymphocytic-B_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MALT1 FCRL5 WDFY4 KMO FCMR

1.17e-05188705a7158b5c94e6b356877f016e52f2c24a3f5d24d2
ToppCell10x5'-blood-Lymphocytic_B-Naive_B_cells|blood / Manually curated celltypes from each tissue

FCRL5 KLHL14 WDFY4 KMO FCMR

1.17e-051887052b3560b28f9df6f4d4a3e0a4acfa6c7d964ad0fe
ToppCellMultiple_Sclerosis-Lymphocyte-B-B_naive|Multiple_Sclerosis / Disease, Lineage and Cell Type

CLCN4 FCRL5 KLHL14 KMO FCMR

1.17e-0518870519b7f92ca46c15b2ac7bba8827eeb85496cdc5f0
ToppCellMesenchymal_cells-Osteoblasts|World / Lineage and Cell class

B3GALT2 BMP1 GXYLT2 CPZ DYNC1I1

1.17e-0518870589f7f5a51be7e046a63e2413f86c521ae4b6718f
ToppCell3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FCRL5 WDFY4 KMO CYFIP2 FCMR

1.20e-05189705a12ca69eebc88725272c89d71a57fc6ce0c06813
ToppCell10x5'-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue

FCRL5 KLHL14 WDFY4 KMO FCMR

1.20e-051897059837dca502c9a7f42efb0bc74f3e88e7461e7dc8
ToppCellCOVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass

CLCN4 FCRL5 WDFY4 KMO FCMR

1.23e-0519070540b5e9e8f8fd8d84cb5b43e67b49267082348e9f
ToppCellCOVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass

CLCN4 FCRL5 WDFY4 KMO FCMR

1.23e-05190705a37a32dc1b931562a6660074e19d5598efc65284
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CLCN4 FCRL5 KLHL14 KMO FCMR

1.27e-051917052feab42ac6d29fa4eac78f3f78a5f8aa0a559523
ToppCell5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FCRL5 KLHL14 WDFY4 KMO FCMR

1.27e-051917058c35fccc4617694eae1e55b1107841ffe7f1bac8
ToppCellwk_15-18-Hematologic_Lymphocytic-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

FCRL5 KLHL14 KMO CYFIP2 FCMR

1.30e-0519270547fec69fccbabf9db95e5a1246c67bddf89bc76b
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CLCN4 FCRL5 KLHL14 KMO FCMR

1.33e-05193705cf4ba50aa4a00d1ba22fc7626d49a4104377d5d9
ToppCellnormal-na-Lymphocytic_B-B_naive|normal / PBMC cell types (v2) per disease, treatment status, and sex

CLCN4 FCRL5 KLHL14 KMO FCMR

1.33e-0519370598279a3c69f1df062c4a8333e46c8fd649bf86b1
ToppCellnormal-na-Lymphocytic_B-B_naive-female|normal / PBMC cell types (v2) per disease, treatment status, and sex

CLCN4 FCRL5 KLHL14 KMO FCMR

1.33e-05193705dd199163fc13f3d411fe741cf003237064349e22
ToppCellmild-Lymphocytic-B_cells_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

FCRL5 KLHL14 WDFY4 KMO FCMR

1.36e-05194705fad1986cba9cd23ac68e639d7335fbcd6ae2a4e7
ToppCellCOVID-19_Moderate-B_naive|COVID-19_Moderate / disease group, cell group and cell class

CLCN4 FCRL5 KLHL14 KMO FCMR

1.36e-051947058c41a37467bfd4966ecd09dde68c543dc01b6ad0
ToppCellwk_20-22-Hematologic_Lymphocytic-B-Immature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

FCRL5 KLHL14 KMO CYFIP2 FCMR

1.36e-05194705f957cec2f309d726e095d18a7da32789dca92a36
ToppCell10x5'v1-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

KREMEN2 FCRL5 KLHL14 KMO FCMR

1.36e-051947054a4cc61193344bb151439f63d0584abddde47cf0
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_naive|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

CLCN4 FCRL5 KLHL14 WDFY4 FCMR

1.40e-05195705b74645072a063732d5be43036ce0e9568eff3d14
ToppCellcontrol-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

FCRL5 KLHL14 WDFY4 KMO FCMR

1.40e-05195705ff7956624b36df34e55295b295a71585accf07bd
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_naive-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CLCN4 FCRL5 KLHL14 WDFY4 FCMR

1.40e-051957054b882a71f0e02fef5580e9d9bc42245cf9df2e57
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CLCN4 FCRL5 KLHL14 WDFY4 FCMR

1.43e-05196705d7e6c89cb49933b4a86d26d15f6772f2481d37ef
ToppCellCOVID-19_Mild-Lymphoid_B-B_naive|COVID-19_Mild / Disease group, lineage and cell class

CLCN4 FCRL5 KLHL14 KMO FCMR

1.43e-051967054b3ceb1f85be0fa8d53dc5548326ab0a5239a8b9
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CLCN4 FCRL5 KLHL14 WDFY4 FCMR

1.43e-05196705fcbfd8c4771d99a45fc53e482ef98edabe8ef591
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CLCN4 FCRL5 KLHL14 WDFY4 FCMR

1.43e-05196705f45cb8f714ae7ac800768df65f299b98a2d42962
ToppCellBronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FCRL5 KLHL14 WDFY4 KMO FCMR

1.43e-05196705de43dd0697e1daf4d50800957cf0b27b54a7a333
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

1.47e-05197705e4b4fa219322b3250b482f8e242f41e8b05485db
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FCRL5 WDFY4 KMO CYFIP2 FCMR

1.51e-05198705824461cf44098440ba8bc0df96735423ac65bda1
ToppCellLPS_IL1RA-Hematopoietic_Lymphocytic-B_cells-B-cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

1.54e-051997050eb8c72edcd34fe0f7ab9438c9c872d63576ef3a
ToppCellLPS_IL1RA-Hematopoietic_Lymphocytic-B_cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

FCRL5 KLHL14 WDFY4 CYFIP2 FCMR

1.54e-051997052cdc8ae6357723b9e7c0c66be656e6f748a6aa2d
ToppCellControl_saline-Hematopoietic_Lymphocytic-B_cells|Control_saline / Treatment groups by lineage, cell group, cell type

KLHL14 WDFY4 KMO CYFIP2 FCMR

1.54e-05199705a984b83d6e143c1e497726da09d8e1acf1f59a74
ToppCellControl_saline-Hematopoietic_Lymphocytic-B_cells-B-cells|Control_saline / Treatment groups by lineage, cell group, cell type

KLHL14 WDFY4 KMO CYFIP2 FCMR

1.54e-051997058913a2f255f42a684221fa0c812e254aa43d8704
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-B-B_naive|COVID-19_Mild / Disease, condition lineage and cell class

CLCN4 FCRL5 KLHL14 WDFY4 KMO

1.58e-05200705e6a43eff47195e1d39530ad49ad908fc06a8b038
ToppCellMS-Multiple_Sclerosis-Lymphocyte-B-B_naive|Multiple_Sclerosis / Disease, condition lineage and cell class

CLCN4 FCRL5 KLHL14 WDFY4 KMO

1.58e-052007054d16545608aa4289a5e406512100c617ccee6a97
ToppCellmild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CLCN4 FCRL5 KLHL14 WDFY4 KMO

1.58e-05200705222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCellsevere-B_naive|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CLCN4 FCRL5 KLHL14 WDFY4 KMO

1.58e-05200705306df1f498ac2188eaf9f2a8d002bb73bdb9642d
ToppCellTracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FCRL5 WDFY4 KMO CYFIP2 FCMR

1.58e-052007054f7be296be0cd54cfc62cc93263fde26210c61f4
ToppCellmild-B_naive|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CLCN4 FCRL5 KLHL14 WDFY4 KMO

1.58e-05200705d0467cab6a42bf780aa49046bf3231ca161dc144
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

GXYLT2 TECRL NMBR KLHL14

3.98e-051217042ae870f822488799cd0ad85e7f72af64e33a867f
ToppCellStriatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Fos_(dSPN,_IEG+)-|Striatum / BrainAtlas - Mouse McCarroll V32

CYP4B1 RHBDL1 KLHL14

4.88e-0545703cce61a18a2d2ac9c3113ef7d9fe8adf70bad773c
ToppCellStriatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Fos_(dSPN,_IEG+)|Striatum / BrainAtlas - Mouse McCarroll V32

CYP4B1 RHBDL1 KLHL14

4.88e-054570308e956e0a428432382ecc13f293f20154fac042c
ToppCellPND01-03-samps-Lymphocyte-B_cell-B_cell_1|PND01-03-samps / Age Group, Lineage, Cell class and subclass

RHBDL1 KLHL14 CYFIP2 FCMR

4.96e-051287045d82247ceda55017628720ed8b6c36ff7cec8437
ToppCellPND01-03-samps-Lymphocyte|PND01-03-samps / Age Group, Lineage, Cell class and subclass

RHBDL1 KLHL14 CYFIP2 FCMR

4.96e-05128704d3158825a2178244b57ac5ad2676617fd58d8466
ToppCellPND01-03-samps-Lymphocyte-B_cell|PND01-03-samps / Age Group, Lineage, Cell class and subclass

RHBDL1 KLHL14 CYFIP2 FCMR

4.96e-051287047661402dd7cd533c1bfe8d9247cecd88c1be9a5e
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Eya1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

GXYLT2 FCRL5 NMBR KLHL14

5.92e-05134704657ad905b40ec3f82acdef824431b8276d291ef7
ToppCellControl-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

KREMEN2 FCRL5 WDFY4 FCMR

8.71e-05148704662c057030effc9eb61216e81d3967e6983c244f
Diseaseobesity

CMKLR2 SLC8A1 PTPRG TECRL MMP26

1.80e-04241645EFO_0001073
Diseaseneuroblastoma

MALT1 CPZ GREB1

2.07e-03116643EFO_0000621
DiseaseCombined immunodeficiency

MALT1 NHEJ1

3.60e-0341642C0494261
DiseaseQRS duration

SLC8A1 MFHAS1 MAP3K7 DYNC1I1

4.03e-03298644EFO_0005055
DiseaseThromboembolism

NMBR MMP26

4.13e-0344642HP_0001907

Protein segments in the cluster

PeptideGeneStartEntry
YHYTQWPDMGVPEYA

PTPRG

1021

P23470
PASLYCPHMVSWEEY

ACSM6

426

Q6P461
YPNNYPNSMECHWVI

CDCP2

161

Q5VXM1
VYYFAHLWDGNPPMA

GVINP1

1666

Q7Z2Y8
YWEPEALYTLCYFMH

BTBD11

461

A6QL63
VEYHTPWYMAELFPF

CLCN4

321

P51793
ECFMAYLYPLQWQHP

DENND3

231

A2RUS2
PEYPNGYSAHMHCVW

BMP1

336

P13497
KDYFHWCYLVPQHGM

ADAMTS16

1191

Q8TE57
NQSSIMYPTYWYHDP

MMP26

221

Q9NRE1
MHLDYYCNKNNWAPP

RBM46

396

Q8TBY0
GVKAYSCPMWAPHSY

OTUD4

706

Q01804
ANFYPETWVYMHPSQ

TIPARP

446

Q7Z3E1
IFCWFPNHILYMYRS

NMBR

276

P28336
YYRQWTVPRPSHMDY

GREB1

1311

Q4ZG55
AWYKFPCYVQNEVPH

MFHAS1

846

Q9Y4C4
MVPYVDLEHQGTYWC

MALT1

276

Q9UDY8
PSTVPYNIQFWCGMY

MTMR8

486

Q96EF0
VMLTIDYTWHPIYPQ

KIAA1109

656

Q2LD37
PTLEPACLSFWYHMY

TMPRSS15

416

P98073
DHWIIAPPFYTPNYC

BMP15

306

O95972
NADYVYDVMWSPVHP

DYNC1I1

531

O14576
YDVMWSPVHPALFAC

DYNC1I1

536

O14576
YVYDVMWSPTHPALF

DYNC1I2

526

Q13409
PQILYQFYHEDMPLW

FCRL5

501

Q96RD9
VFWEPALHQPMYYFL

OR51I1

51

Q9H343
LIFWDSCLHNPMYFF

OR5B3

46

Q8NH48
FPCQWNYRPDHCMYG

GXYLT2

331

A0PJZ3
PLPYYTAAHAMSWCL

MAP3K7

121

O43318
WRYCDIPSCHMPGYL

KREMEN2

111

Q8NCW0
IFMCWVGDVYPVYQP

NDUFB8

141

O95169
AFPYAAYSMPASWLH

PAQR6

131

Q6TCH4
FHRLWSAMQFVYCIP

CYFIP2

1151

Q96F07
QHFLYEVPPWVMCRF

IRAK1

16

P51617
NWVATYCPHIPYVMK

B3GALT2

236

O43825
PGIWPSHKRYIEYMC

GAK

546

O14976
NGEYVPWLYCYDPVM

KLHL14

481

Q9P2G3
CYDPVEDYWMHVQNT

KLHL24

516

Q6TFL4
YAMEPNYLHIWPRNT

KMO

206

O15229
IDMAWPYFLDCHRYF

CPZ

136

Q66K79
WMDEYKEHFYNRNPP

GALNT4

386

Q8N4A0
MWNAPSYLHLNPASY

HYAL4

391

Q2M3T9
TLMPYPELYNWDSCA

DRC7

136

Q8IY82
VFPNALYTHCYNWPE

DCAF12L1

426

Q5VU92
WFLYCMALYPEHQHR

CYP4B1

326

P13584
WCPMSPEFYREYVAI

ERCC3

511

P19447
YVFINQMCYHLALPW

LRRC8D

146

Q7L1W4
APEAMHPWELFVKYY

RUNDC1

466

Q96C34
EPHYQPWSYMAHTGF

RUNDC1

566

Q96C34
DYVMYPPHLYSSPWC

TATDN2

366

Q93075
HWLAMSSACYNPFIY

PRLHR

321

P49683
PYFCDPWAQDYMHPK

FER1L5

1336

A0AVI2
KIDPSMLPARWFCYY

MORC4

441

Q8TE76
MLPARWFCYYNSHPK

MORC4

446

Q8TE76
MVCYLYWETFPSISH

LINC00862

1

A6NCI5
WQLIHMYGFVEPYPD

SETD6

291

Q8TBK2
PFYWNFHCMLASPSL

NHEJ1

116

Q9H9Q4
CWFESGSMPYAQVHY

IARS1

526

P41252
MTFAICWLPYHIYFI

TACR3

306

P29371
WYFYRHRSCPPPVFM

RHBDL1

186

O75783
KPHQYPAICSYHWDV

SPEM1

136

Q8N4L4
PLYISYVAMNFHWPF

CMKLR2

91

P46091
FNQHPDVFYLYEPMW

CHST7

121

Q9NS84
WGSDPQYQYMPFEHC

CLCN1

16

P35523
DSPYYEHFYMALEPW

POGLUT3

396

Q7Z4H8
EHFYMALEPWKHYVP

POGLUT3

401

Q7Z4H8
YPPAMDWIFQCISYH

VPS35L

391

Q7Z3J2
PYMKCVAWYLNYDPE

MIOS

61

Q9NXC5
WFHLPYLFQMPAYAS

FCMR

141

O60667
TMYCKSVGYPHPDWI

NPTN

256

Q9Y639
GRTCNDYMQYPVFPW

WDFY4

2561

Q6ZS81
PISYMAVIIQFCWHF

XKR4

366

Q5GH76
EVLHWVTHFPYPMYS

STARD7

211

Q9NQZ5
PNYNPFTWMFFLVSC

TECRL

286

Q5HYJ1
CMYYQTKSPFWASEP

TARM1

196

B6A8C7
PSCFDYVMHFLTVFW

SLC8A1

771

P32418